English | Español

Regulatory
+ Regulatory
Press release submission | Oct 30, 2021

Akebia Announces Otsuka's Submission of Initial Marketing Authorization Application to the European Medicines Agency for Vadadustat for the Treatment of Patients with Anemia due to Chronic Kidney Disease
+ Regulatory
Press release submission | Oct 29, 2021

HUYABIO Announces FDA Clearance to Initiate a Phase 1 Trial of SHP2 Inhibitor in Patients with KRAS and EGFR Mutated Tumors
+ Regulatory
Press release submission | Oct 24, 2021

MSD joins hands with Emirates Oncology Society and Friends of Cancer Patients for EMBRACE campaign to support Breast Cancer Awareness ·
+ Regulatory
Bree Gonzales | Oct 21, 2021

Advocates worried about reduction in Medicaid funding for people 'who are going to need that long-term service'
+ Regulatory
Press release submission | Oct 21, 2021

Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed in Phase 1 Study of DSP-0390 in Patients with Recurrent High-Grade Glioma
+ Regulatory
Bree Gonzales | Oct 20, 2021

Veterans Affairs to halt Office of Community Care while continuing to be a 'veteran-centric organization'
+ Regulatory
Press release submission | Oct 20, 2021

Senhwa Presents Positive Initial Data from Phase 2 Clinical Trial of Silmitasertib (CX-4945) in Moderate COVID-19 Patients At the ISIRV-WHO Conference
+ Regulatory
Press release submission | Oct 15, 2021

Once-Daily AZSTARYS® (serdexmethylphenidate and dexmethylphenidate), First and Only Product Containing Dexmethylphenidate Prodrug for ADHD in Patients Aged 6 Years and Older, Significantly Reduces ADHD Symptoms

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes